Pulmonary Fibrosis Latest Advances

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Journal: Pulmonology

Published: June 24, 2026

A profile on inhaled treprostinil for pulmonary hypertension.

Journal: Expert review of respiratory medicine

Published: June 23, 2026

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Journal: bioRxiv : the preprint server for biology

Published: June 22, 2026

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Journal: Respiratory medicine

Published: June 21, 2026

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Journal: Current opinion in pulmonary medicine

Published: June 18, 2026

20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway.

Journal: Chemical research in toxicology

Published: June 18, 2026

Effect of Dietary Nitrate Supplementation on Exercise Performance in Hypoxic IPF (EDEN-OX3): a double-blind, placebo-controlled, randomised crossover study.

Journal: Thorax

Published: June 17, 2026

Therapeutic applications and prospects of inhalable mesoporous silica nanoparticles in pulmonary diseases.

Journal: Nanoscale

Published: June 16, 2026

Nanochemical modulation of ECM-driven pseudo-resistance: convergent microenvironmental pathways in COVID-19 and cancer.

Journal: Chemical communications (Cambridge, England)

Published: June 16, 2026

Potential Roles of Gut Microbiome and Metabolomes in Interstitial Lung Disease: Evidence across Preclinical and Clinical Research.

Journal: Journal of applied microbiology

Published: June 15, 2026

Pulmonary fibrosis: Emerging targets and novel therapeutics.

Journal: The Journal of international medical research

Published: June 15, 2026

Corrigendum to "Pharmacological effects of indole alkaloids from Alstonia scholaris (L.) R. Br. on pulmonary fibrosis in vivo" [J. Ethnopharmacol. 267 (2021) 113506].

Journal: Journal of ethnopharmacology

Published: June 13, 2026

Pulmonary Fibrosis Latest Advances

Find the Latest Research About Pulmonary Fibrosis

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

Association between smoking and prognosis in idiopathic pulmonary fibrosis: A systematic review and meta-analysis.

A profile on inhaled treprostinil for pulmonary hypertension.

A profile on inhaled treprostinil for pulmonary hypertension.

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Epigenetic de-repression of basal cell metaplasia in aging AT2 cells is a risk factor for idiopathic pulmonary fibrosis (IPF).

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Corrigendum to "A new perspective on idiopathic pulmonary fibrosis research: From multi-dimensional mechanistic exploration to advances in precision therapy" [Respir. Med. 260 (2026) 1-15].

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

Toward precision imaging in interstitial lung disease: advances in quantitative imaging and artificial intelligence.

20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway.

20-Hydroxyeicosatetraenoic Acid Ameliorates Nickel Nanoparticle-Induced Epithelial-Mesenchymal Transition by Modulating the FFAR1/NF-kB Pathway.

Effect of Dietary Nitrate Supplementation on Exercise Performance in Hypoxic IPF (EDEN-OX3): a double-blind, placebo-controlled, randomised crossover study.

Effect of Dietary Nitrate Supplementation on Exercise Performance in Hypoxic IPF (EDEN-OX3): a double-blind, placebo-controlled, randomised crossover study.

Therapeutic applications and prospects of inhalable mesoporous silica nanoparticles in pulmonary diseases.

Therapeutic applications and prospects of inhalable mesoporous silica nanoparticles in pulmonary diseases.

Nanochemical modulation of ECM-driven pseudo-resistance: convergent microenvironmental pathways in COVID-19 and cancer.

Nanochemical modulation of ECM-driven pseudo-resistance: convergent microenvironmental pathways in COVID-19 and cancer.

Potential Roles of Gut Microbiome and Metabolomes in Interstitial Lung Disease: Evidence across Preclinical and Clinical Research.

Potential Roles of Gut Microbiome and Metabolomes in Interstitial Lung Disease: Evidence across Preclinical and Clinical Research.

Pulmonary fibrosis: Emerging targets and novel therapeutics.

Pulmonary fibrosis: Emerging targets and novel therapeutics.

Corrigendum to "Pharmacological effects of indole alkaloids from Alstonia scholaris (L.) R. Br. on pulmonary fibrosis in vivo" [J. Ethnopharmacol. 267 (2021) 113506].

Corrigendum to "Pharmacological effects of indole alkaloids from Alstonia scholaris (L.) R. Br. on pulmonary fibrosis in vivo" [J. Ethnopharmacol. 267 (2021) 113506].